Recombinant Human SP-C Protein，His

Surfactant Protein C (SP-C) is a pivotal component of pulmonary surfactant, crucial for reducing surface tension in the alveoli, thereby preventing lung collapse during exhalation and ensuring efficient gas exchange. The gene encoding SP-C is located on chromosome 8, and mutations or deficiencies in this protein can lead to severe respiratory conditions, such as surfactant dysfunction disorders and interstitial lung disease. The study of SP-C has become increasingly significant, particularly in understanding its role in lung health and disease, as well as in the development of therapeutic interventions. Recombinant SP-C proteins, produced using biotechnological methods, have emerged as potential therapeutic agents in treating surfactant abnormalities. Research has focused on the structure-function relationship of SP-C, exploring how modifications in the protein can enhance its stability and functionality. Furthermore, investigations into the molecular mechanisms by which SP-C interacts with lipids and other proteins in surfactant complexes provide valuable insights into respiratory physiology. Recent advances in gene therapy and protein engineering aim to correct SP-C deficiencies, offering hope for patients suffering from related pulmonary disorders. This underscores the importance of SP-C recombinant protein research in developing novel strategies for the prevention and treatment of various lung diseases.